Access our 2024 TIDES Europe Investor Recap Call
The Future of API Synthesis
Historically, given enough time and resources, almost any small molecule API will succumb to “total synthesis” – first in medicinal chemistry and then in process chemistry. The greatest challenge facing the process chemist, both then and now, is to produce the molecules under a state of control, with a reproducible impurity profile, in an economical fashion, and at increasing scale. These seemingly simple but high-level goals arguably cause the most problems and influence route design the most. In addition, the regulatory and toxicology landscape has changed and a much more rigorous approach to impurity control, especially of potential genotoxins, has emerged (and rightly so).
Read what lies ahead for API synthesis in this informative article.
Link to Full Article